- The first human trial for a coronavirus vaccine started on Monday, 16 March
- The vaccine will be administered to 45 young, healthy volunteers in different doses
- The goal of the trial is to find out if the vaccines have worrisome side effects before expanding the testing to more people
- Health experts said it may take up to 18 months before a potential vaccine can be fully developed for release
As coronavirus spreads across the world and the death toll climbs every day, health experts have been working to develop a vaccine to combat the deadly virus.
The efforts appear to be yielding results as the United States government announced that a clinical trial to test a coronavirus vaccine had begun on Monday.
The first human participant will receive an experimental dose to test for potential side effects, but they will not actually be infected with the Covid-19 virus, according to the source.
Metro UK reports that an anonymous source said the trial which is being funded by the National Institute of Health (NIH), will take place at the Kaiser Permanente Washington Health Research Institute in Seattle.
Briefly.co.za gathers that it may take up to 18 months before any potential vaccine can be fully validated, according to health experts.
The vaccine trial will be carried out on 45 young, healthy volunteers in different doses, which were co-developed by the NIH and Moderna Inc.
Those who participate in the trial won't get infected as the shots do not contain the deadly virus.
The goal of the trial is to find out if the vaccines have worrisome side effects before expanding the tests to more people.
The Daily Mail in its own version of the report also noted that the participants would not be infected with the coronavirus.
The newspaper notes that the test will be extended to more people if the vaccines did not show negative side effects in the first trial.
Various research groups across the world are all making concerted efforts to create a vaccine as Covid-19 spreads across countries and continents.
An earlier report by Time magazine had stated that the Chinese government had begun clinical trials to test a drug for the coronavirus infection.
The international magazine reports that a new antiviral drug called Remdesivir, which is aimed at infectious diseases such as Ebola and SARS, was to be tested in a Beijing-based China-Japan Friendship Hospital to see if it would curb the new strain of the coronavirus.
Enjoyed reading our story? Download BRIEFLY's news app on Google Play now and stay up-to-date with major South African news!